Availability of Program Application Instructions for Subtitle C of the Developmental Disabilities Assistance and Bill of Rights Act of 2000, Protection and Advocacy Systems To Expand the Public Health Workforce, 1760-1762 [2022-00401]
Download as PDF
<![CDATA[
1760
Federal Register / Vol. 87, No. 8 / Wednesday, January 12, 2022 / Notices
that captures a core set of individual
level data relevant for determining the
range of necessary LTSS.
The Federal vision for the NWD
System gives states flexibility in
determining how best to organize,
structure and operate the various
functions of their NWD System. States
continue to integrate, in some cases
restructure, and over time strengthen
their existing programs in order to
realize the joint ACL/CMS/VHA vision
for a fully coordinated and integrated
system of access. These efforts are
supported by a variety of initiatives,
including the VHA’s Veteran Directed
Care (VDC) program, an evidence-based
self-directed program where personcentered counselors from aging and
disability network agencies within a
state’s NWD System provide facilitated
assessment and care planning, arrange
fiscal management services, and provide
ongoing counseling and support to
Veterans, their families, and caregivers.
The NWD System Management Tool
(NWD MT) provides a platform for data
collection necessary to evaluate the four
primary functions of a NWD System:
State Governance and Administration,
Public Outreach and Coordination with
Key Referral Sources, Person Centered
Counseling, and Streamlined Access to
Public LTSS Programs. In addition, this
tool will include data collection for the
VDC program to collect qualitative and
quantitative data elements necessary to
evaluate the impact of the VDC program.
The VDC Tool will track key
performance measures and identify best
practices and technical assistance
needs.
The NWD MT and the VDC Tool will
enable ACL and its partners to collect
and analyze data elements necessary to
assess the progress of the NWD System
model, track performance measures, and
identify gaps and best practices. These
tools have been designed in close
collaboration with states and are
intended to simplify grant reporting
requirements to reduce burden on local
and state entities and will provide a
consistent, streamlined and coordinated
statewide approach to help states govern
their NWD System and manage their
programs efficiently.
The proposed data collection tools
may be found on the ACL website for
review at: https://www.acl.gov/aboutacl/public-input.
Estimated Program Burden: ACL
estimates the burden of this collection
of information as follows:
Fifty-six lead NWD System state and
territorial agencies will respond to the
NWD MT bi-annually and it will take
approximately half an hour to collect
the data and an additional half hour to
input the data into a web-based system.
Additionally, an estimated 900 local
agencies will take approximately two
Number of
respondents
Respondent/data collection activity
Responses
per
respondent
Hours per
response
Annual
burden hours
NWD Management Tool data collection and entry—State Level ....................
NWD Management Tool data collection and entry—Local Level ...................
Veteran Directed Care Tool .............................................................................
56
900
275
2
2
12
1.0
2.0
0.5
112
3,600
1,650
Total ..........................................................................................................
1,231
........................
........................
5,362
Dated: January 6, 2022.
Alison Barkoff,
Principal Deputy Administrator.
[FR Doc. 2022–00399 Filed 1–11–22; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
lotter on DSK11XQN23PROD with NOTICES1
hours to collect and submit the data to
their lead NWD System state agency.
There may be several lead NWD System
state and territorial agencies who will be
submitting on behalf of their local
agencies. Therefore, the approximate
burden for the local level agencies may
be thirty minutes less than anticipated.
If all state and local agencies respond biannually, the national burden estimate
for the NWD MT would be a total of
3,712 hours annually. This burden
estimate is calculated based upon a
sample of ADRC/NWD grantees. Each
state entity submitting data will receive
local-level data from designated NWD
System entities. The estimated response
burden includes time to review the
instructions, gather existing
information, and complete and review
the data entries in a web-based system.
An estimated 275 VDC program
entities will respond to the VDC Tool on
a monthly-basis, all of which are also
NWD local-level entities, for an annual
burden of 1,650 hours. This burden
estimate is calculated based upon
information provided by current VDC
program providers testing an
abbreviated version of the VDC Tool.
The NWD MT and the VDC Tool have
been developed to increase ease and
uniformity of reporting and improve the
ability of ACL to manage and analyze
data.
Availability of Program Application
Instructions for Subtitle C of the
Developmental Disabilities Assistance
and Bill of Rights Act of 2000,
Protection and Advocacy Systems To
Expand the Public Health Workforce
Title: Expanding the Public Health
Workforce within the Disability
VerDate Sep<11>2014
17:04 Jan 11, 2022
Jkt 256001
Networks: Protection and Advocacy
Systems.
Announcement Type: Initial.
Statutory Authority: The statutory
authority for grants under this program
announcement is Section 2501 of the
American Rescue Plan Act of 2021 (Pub.
L. 117–2) and awards authorized under
Subtitle C of the Developmental
Disabilities Assistance and Bill of Rights
Act of 2000 (42 U.S.C 15041 et seq.),
Protection and Advocacy Systems, shall
be provided funding under this
opportunity.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.630.
The deadline date for the
submission of the Expanding the Public
Health Workforce within Disability
Networks: Protection and Advocacy
DATES:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Systems is 11:59 p.m. Eastern Time
February 11, 2022.
I. Funding Opportunity Description
The Administration for Community
Living (ACL) announced a new funding
opportunity to expand the public health
workforce within the disability
networks. Public health promotes and
protects the health of people and the
communities where they live, learn,
work, and play. The disability networks
funded by the Administration for
Community Living (ACL) play an
essential role in that work. The
disability networks consist of trusted
organizations and programs that reach
and provide services and supports to
people with disabilities in every
community throughout the nation,
including those related to public health
E:\FR\FM\12JAN1.SGM
12JAN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 8 / Wednesday, January 12, 2022 / Notices
such as health and wellness education
and information, counseling, case
management and guidance related to
health and social needs, as well as how
to access those supports. These
networks have over 50 years of
community experience and possess
intimate knowledge of the public health
and other resources available and the
needs of people with disabilities in their
direct area.
As part of its ongoing COVID–19
response efforts, the Biden-Harris
Administration is investing federal
funds through the American Rescue
Plan Act of 2021 (ARPA) 1 to recruit,
hire, and train public health workers to
respond to the pandemic and prepare
for future public health challenges.
Specifically, the Secretary of the U.S.
Department of Health and Human
Services (HHS) will ‘‘carry out activities
related to establishing, expanding, and
sustaining a public health workforce
. . . ,’’ ARPA § 2501(a), and funds may
be used to support costs, including
wages and benefits, of a range of public
health professionals including but not
limited to social support professionals,
community health workers,
communication and policy experts and
‘‘. . . other positions as may be required
to prevent, prepare for, and respond to
COVID–19 . . . ,’’ ARPA § 2501(b)(1).
To help advance these efforts, ACL
has created the Expanding the Public
Health Workforce within Disability
Networks program. This program aims
to increase through the support of wages
and benefits the number of public
health professionals within the
disability networks to address the
unique needs of individuals with
disabilities. Public health professionals
supported through this program may
provide a wide range of public health
services and supports, including
provision of culturally affirmative and
linguistically accessible information,
access assistance for vaccines and
boosters, transition and diversion from
high-risk congregate settings to
community living, provision and
connections to health and wellness
programs, activities that address social
isolation and social determinants of
health, and other activities that support
the public health and wellbeing of
people with disabilities.
Protection and Advocacy Systems
(P&As) under the Developmental
Disabilities Assistance and Bill of Rights
Act (DD Act)—the eligible entities for
this opportunity—shall be provided
funding to support new staff or increase
the full-time equivalent (FTE) of
1 American Rescue Plan Act of 2021, Public Law
117–2, 135 Stat 4 (Mar. 11, 2021).
VerDate Sep<11>2014
17:04 Jan 11, 2022
Jkt 256001
existing staff under this opportunity to
carry out public health services and
supports. Although not required for
funding, grantees are encouraged to
explore options for funding to sustain
the new FTE after the end of the grant.
There is no cost sharing or matching
requirement for this funding.
Award recipients will be required to
submit annual progress reports in the
form of a written summary on the
number of full-time equivalents (FTEs)
funded, type of public health
professional(s) hired, and the activities
they are engaged in to advance public
health. To be eligible to receive this
grant, the P&As must submit a Letter of
Assurance to ACL containing all the
assurances required, (see below,
‘‘Section III. Eligibility Criteria and
Other Requirements’’ and ‘‘Section IV.
Submission Information’’). P&As that do
not submit a Letter of Assurance or
otherwise indicate no desire to receive
funds, will be excluded from receiving
funds.
ACL may extend deadlines based on
the need of the COVID–19 response,
e.g., to meet unanticipated issues related
to COVID–19 and/or to allow impacted
P&As that missed the cut-off date to
submit a letter of assurance for
consideration. ACL intends to issue
notices of award as soon as possible
with an estimated start date of March 1,
2022. However, the actual award may be
released earlier or later than that date.
Because the total amount awarded to
each grantee is contingent upon the total
number of grantees applying for
funding, grant awards will be issued
after ACL receives responses from all
eligible P&As. Regardless of the date of
award, the funding will be available
until September 30, 2024. Grantees may
use the funds over any period of time
before this date but are encouraged to
use the funding as soon as possible to
have the greatest impact.
II. Award Information
1. Funding Instrument Type
These awards will be made in the
form of new grants, evenly distributed
to eligible entities.
2. Anticipated Total Funding per Budget
Period
Awards made under this
announcement will have an estimated
start date of March 1, 2022 and an end
date of September 30, 2024.
The total available funding for this
opportunity is $6,384,000.
Eligible entities who do not complete
assurance requirements below, or
otherwise indicate no desire to receive
funds will be excluded from receiving
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
1761
funds. This will have the effect of
increasing the amount of funds available
for eventual recipients.
ACL will distribute the $6,384,000
evenly to all eligible entities to ensure
a sufficient level of funding to provide
substantive support for the public
health workforce, which equates to a
minimum award of $112,000. This
figure is based on the current number of
eligible entities and would rise if some
eligible entities refuse or are deemed
ineligible.
III. Eligibility Criteria and Other
Requirements
1. Eligible Entities
The eligible entity for these awards is
designated by ACL as Protection and
Advocacy Systems authorized under
Subtitle C of the Developmental
Disabilities Assistance and Bill of Rights
Act of 2000.
2. Match
Cost Sharing or Matching is not
required.
3. Other Requirements
A. Letter of Assurance
A Letter of Assurance is required to be
submitted by the eligible entity in order
to receive an award. The Letter of
Assurance must include the following:
1. Assurance that the award recipient
is the agency or entity designated as the
Protection and Advocacy System in the
state or territory under section 143 of
the DD Act (42 U.S.C. 15042).
2. Assurance that funds will be spent
in ways consistent with the purpose of
the funding to support the cost of wages
and benefits for public health
professionals, directly or through
contract such as:
• Case investigator,
• Contact tracer,
• Social support specialist,
• Community health worker,
• Public health nurse,
• Disease intervention specialist,
• Epidemiologist,
• Program manager,
• Laboratory personnel,
• Informaticians,
• Communication and policy experts,
• Other positions as may be required
to prevent, prepare for, and respond to
COVID–19.
3. Assurance to provide semi-annual
federal financial reports and annual
program reports that include the
number and type of full-time
equivalents hired, and activities
performed to advance public health.
B. DUNS Number
All grant applicants must obtain and
keep current a D–U–N–S number from
E:\FR\FM\12JAN1.SGM
12JAN1
1762
Federal Register / Vol. 87, No. 8 / Wednesday, January 12, 2022 / Notices
Dun and Bradstreet. It is a nine-digit
identification number, which provides
unique identifiers of single business
entities. The D–U–N–S number can be
obtained from: https://iupdate.dnb.com/
iUpdate/viewiUpdateHome.htm.
C. Intergovernmental Review
Executive Order 12372,
Intergovernmental Review of Federal
Programs, is not applicable to these
grant applications.
IV. Submission Information
1. Letter of Assurance
To receive funding, eligible entities
must provide a Letter of Assurance
containing all the information outlined
in Section III above.
Letters of Assurance should be
addressed to: Jennifer Johnson, Deputy
Commissioner, Administration on
Disabilities, Administration for
Community Living.
Letters of Assurance should be
submitted electronically via email to
PHWF@acl.hhs.gov.
2. Submission Dates and Times
To receive consideration, Letters of
Assurance must be submitted by 11:59
p.m. Eastern Time on February 11, 2022.
Letters of Assurance should be
submitted electronically via email and
have an electronic time stamp
indicating the date/time submitted.
VII. Agency Contacts
1. Programmatic and Submission Issues
Direct programmatic and submission
inquiries to PHWF@acl.hhs.gov.
Dated: January 6, 2022.
Alison Barkoff,
Principal Deputy Administrator.
[FR Doc. 2022–00401 Filed 1–11–22; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket Nos. FDA–2020–E–1817, FDA–
2020–E–1818, and FDA–2020–E–1820]
lotter on DSK11XQN23PROD with NOTICES1
ACTION:
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration,
Notice; correction.
The Food and Drug
Administration (FDA or the Agency)
published a notice in the Federal
Register of November 1, 2021, for the
determination of a regulatory review
SUMMARY:
VerDate Sep<11>2014
17:04 Jan 11, 2022
Jkt 256001
In the Federal Register of November
1, 2021 (86 FR 60252), in FR Doc. 2021–
23725, appearing on page 60253, in the
third column, in section II.,
‘‘Determination of Regulatory Review
Period,’’ in the first two sentences, the
following correction is made:
FDA has determined that the
applicable regulatory review period for
ENHERTU is 1,395 days. Of this time,
114 days occurred during the testing
phase of the regulatory review period,
while 1,281 days occurred during the
approval phase.
[FR Doc. 2022–00404 Filed 1–11–22; 8:45 am]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; ENHERTU; Correction
HHS.
Correction
Dated: January 5, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
Food and Drug Administration
AGENCY:
period for purposes of patent extension
for the human biological product,
ENHERTU. This document corrects that
notice by adjusting the applicable
regulatory review period for the testing
phase and approval phase of the
product, ENHERTU.
DATES: All due dates for submission of
comments, redetermination requests,
and submission of petitions for due
diligence as well as the dates used to
determine the regulatory review periods
for the products noted above remain the
same as originally published.
FOR FURTHER INFORMATION CONTACT:
Beverly Friedman, Office of Regulatory
Policy, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 51,
Rm. 6250, Silver Spring, MD 20993,
301–796–3600.
SUPPLEMENTARY INFORMATION: On
November 1, 2021, the Food and Drug
Administration (FDA or the Agency)
published a notice in the Federal
Register determining the regulatory
review period for the human biological
product ENHERTU. This correction to
the notice adjusts the applicable
regulatory review period of the product
with the number of days occurring
during the testing phase and the
approval phase of the product
ENHERTU.
Health Resources and Services
Administration
Updates to the Bright Futures
Periodicity Schedule
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
ACTION:
Notice.
Effective December 30, 2021,
HRSA accepted recommended updates
to the Bright Futures Periodicity
Schedule, a HRSA-supported guideline
for infants, children and adolescents for
purposes of ensuring that nongrandfathered group and individual
health insurance issuers provide
coverage without cost sharing under the
Public Health Service Act. The updates
to the Bright Futures Periodicity
Schedule are: A new category for
sudden cardiac arrest and sudden
cardiac death risk assessment, a new
category for hepatitis B virus infection
risk assessment, addition of suicide risk
as an element of universal depression
screening for children ages 12–21, and
updated category title from
‘‘Psychosocial/Behavioral Assessment’’
to ‘‘Behavioral/Social/Emotional
Screening,’’ with no revision to the ages
in which the screening occurs (newborn
to 21 years). Finally, two clarifying
references related to dental fluoride
varnish and fluoride supplementation
have been added, with no associated
recommended changes to clinical
practice or health insurance coverage.
Please see https://mchb.hrsa.gov/
maternal-child-health-topics/childhealth/bright-futures.html for additional
information.
FOR FURTHER INFORMATION CONTACT:
Savannah Kidd, M.S. MFT, HRSA/
Maternal and Child Health Bureau by
calling 301–287–2601 or by emailing at
SKidd@hrsa.gov.
SUPPLEMENTARY INFORMATION: The Bright
Futures program has been funded by
HRSA since 1990. A primary focus of
this program is for the funding recipient
to maintain and recommend updates to
the Bright Futures Guidelines for Health
Supervision of Infants, Children and
Adolescents, a set of materials and tools
that provide theory-based and evidencedriven guidance for all preventive care
screenings and well-child visits. One
component of these tools is the Bright
Futures Periodicity Schedule, a chart
that identifies the recommended
screenings, assessments, physical
examinations, and procedures to be
delivered within preventive checkups at
each age milestone. Over the program’s
existence, the Bright Futures Periodicity
Schedule has become the accepted
schedule within the United States for
preventive health services through the
course of a child’s development.
Section 2713 of the Public Health
Service Act (42 U.S.C. 300gg–13), added
by the Patient Protection and Affordable
Care Act (Pub. L. 111–148), requires that
non-grandfathered group health plans
and health insurance issuers offering
SUMMARY:
E:\FR\FM\12JAN1.SGM
12JAN1
]]>Agencies
[Federal Register Volume 87, Number 8 (Wednesday, January 12, 2022)]
[Notices]
[Pages 1760-1762]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00401]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Availability of Program Application Instructions for Subtitle C
of the Developmental Disabilities Assistance and Bill of Rights Act of
2000, Protection and Advocacy Systems To Expand the Public Health
Workforce
Title: Expanding the Public Health Workforce within the Disability
Networks: Protection and Advocacy Systems.
Announcement Type: Initial.
Statutory Authority: The statutory authority for grants under this
program announcement is Section 2501 of the American Rescue Plan Act of
2021 (Pub. L. 117-2) and awards authorized under Subtitle C of the
Developmental Disabilities Assistance and Bill of Rights Act of 2000
(42 U.S.C 15041 et seq.), Protection and Advocacy Systems, shall be
provided funding under this opportunity.
Catalog of Federal Domestic Assistance (CFDA) Number: 93.630.
DATES: The deadline date for the submission of the Expanding the Public
Health Workforce within Disability Networks: Protection and Advocacy
Systems is 11:59 p.m. Eastern Time February 11, 2022.
I. Funding Opportunity Description
The Administration for Community Living (ACL) announced a new
funding opportunity to expand the public health workforce within the
disability networks. Public health promotes and protects the health of
people and the communities where they live, learn, work, and play. The
disability networks funded by the Administration for Community Living
(ACL) play an essential role in that work. The disability networks
consist of trusted organizations and programs that reach and provide
services and supports to people with disabilities in every community
throughout the nation, including those related to public health
[[Page 1761]]
such as health and wellness education and information, counseling, case
management and guidance related to health and social needs, as well as
how to access those supports. These networks have over 50 years of
community experience and possess intimate knowledge of the public
health and other resources available and the needs of people with
disabilities in their direct area.
As part of its ongoing COVID-19 response efforts, the Biden-Harris
Administration is investing federal funds through the American Rescue
Plan Act of 2021 (ARPA) \1\ to recruit, hire, and train public health
workers to respond to the pandemic and prepare for future public health
challenges. Specifically, the Secretary of the U.S. Department of
Health and Human Services (HHS) will ``carry out activities related to
establishing, expanding, and sustaining a public health workforce . . .
,'' ARPA Sec. 2501(a), and funds may be used to support costs,
including wages and benefits, of a range of public health professionals
including but not limited to social support professionals, community
health workers, communication and policy experts and ``. . . other
positions as may be required to prevent, prepare for, and respond to
COVID-19 . . . ,'' ARPA Sec. 2501(b)(1).
---------------------------------------------------------------------------
\1\ American Rescue Plan Act of 2021, Public Law 117-2, 135 Stat
4 (Mar. 11, 2021).
---------------------------------------------------------------------------
To help advance these efforts, ACL has created the Expanding the
Public Health Workforce within Disability Networks program. This
program aims to increase through the support of wages and benefits the
number of public health professionals within the disability networks to
address the unique needs of individuals with disabilities. Public
health professionals supported through this program may provide a wide
range of public health services and supports, including provision of
culturally affirmative and linguistically accessible information,
access assistance for vaccines and boosters, transition and diversion
from high-risk congregate settings to community living, provision and
connections to health and wellness programs, activities that address
social isolation and social determinants of health, and other
activities that support the public health and wellbeing of people with
disabilities.
Protection and Advocacy Systems (P&As) under the Developmental
Disabilities Assistance and Bill of Rights Act (DD Act)--the eligible
entities for this opportunity--shall be provided funding to support new
staff or increase the full-time equivalent (FTE) of existing staff
under this opportunity to carry out public health services and
supports. Although not required for funding, grantees are encouraged to
explore options for funding to sustain the new FTE after the end of the
grant. There is no cost sharing or matching requirement for this
funding.
Award recipients will be required to submit annual progress reports
in the form of a written summary on the number of full-time equivalents
(FTEs) funded, type of public health professional(s) hired, and the
activities they are engaged in to advance public health. To be eligible
to receive this grant, the P&As must submit a Letter of Assurance to
ACL containing all the assurances required, (see below, ``Section III.
Eligibility Criteria and Other Requirements'' and ``Section IV.
Submission Information''). P&As that do not submit a Letter of
Assurance or otherwise indicate no desire to receive funds, will be
excluded from receiving funds.
ACL may extend deadlines based on the need of the COVID-19
response, e.g., to meet unanticipated issues related to COVID-19 and/or
to allow impacted P&As that missed the cut-off date to submit a letter
of assurance for consideration. ACL intends to issue notices of award
as soon as possible with an estimated start date of March 1, 2022.
However, the actual award may be released earlier or later than that
date. Because the total amount awarded to each grantee is contingent
upon the total number of grantees applying for funding, grant awards
will be issued after ACL receives responses from all eligible P&As.
Regardless of the date of award, the funding will be available until
September 30, 2024. Grantees may use the funds over any period of time
before this date but are encouraged to use the funding as soon as
possible to have the greatest impact.
II. Award Information
1. Funding Instrument Type
These awards will be made in the form of new grants, evenly
distributed to eligible entities.
2. Anticipated Total Funding per Budget Period
Awards made under this announcement will have an estimated start
date of March 1, 2022 and an end date of September 30, 2024.
The total available funding for this opportunity is $6,384,000.
Eligible entities who do not complete assurance requirements below,
or otherwise indicate no desire to receive funds will be excluded from
receiving funds. This will have the effect of increasing the amount of
funds available for eventual recipients.
ACL will distribute the $6,384,000 evenly to all eligible entities
to ensure a sufficient level of funding to provide substantive support
for the public health workforce, which equates to a minimum award of
$112,000. This figure is based on the current number of eligible
entities and would rise if some eligible entities refuse or are deemed
ineligible.
III. Eligibility Criteria and Other Requirements
1. Eligible Entities
The eligible entity for these awards is designated by ACL as
Protection and Advocacy Systems authorized under Subtitle C of the
Developmental Disabilities Assistance and Bill of Rights Act of 2000.
2. Match
Cost Sharing or Matching is not required.
3. Other Requirements
A. Letter of Assurance
A Letter of Assurance is required to be submitted by the eligible
entity in order to receive an award. The Letter of Assurance must
include the following:
1. Assurance that the award recipient is the agency or entity
designated as the Protection and Advocacy System in the state or
territory under section 143 of the DD Act (42 U.S.C. 15042).
2. Assurance that funds will be spent in ways consistent with the
purpose of the funding to support the cost of wages and benefits for
public health professionals, directly or through contract such as:
Case investigator,
Contact tracer,
Social support specialist,
Community health worker,
Public health nurse,
Disease intervention specialist,
Epidemiologist,
Program manager,
Laboratory personnel,
Informaticians,
Communication and policy experts,
Other positions as may be required to prevent, prepare
for, and respond to COVID-19.
3. Assurance to provide semi-annual federal financial reports and
annual program reports that include the number and type of full-time
equivalents hired, and activities performed to advance public health.
B. DUNS Number
All grant applicants must obtain and keep current a D-U-N-S number
from
[[Page 1762]]
Dun and Bradstreet. It is a nine-digit identification number, which
provides unique identifiers of single business entities. The D-U-N-S
number can be obtained from: https://iupdate.dnb.com/iUpdate/viewiUpdateHome.htm.
C. Intergovernmental Review
Executive Order 12372, Intergovernmental Review of Federal
Programs, is not applicable to these grant applications.
IV. Submission Information
1. Letter of Assurance
To receive funding, eligible entities must provide a Letter of
Assurance containing all the information outlined in Section III above.
Letters of Assurance should be addressed to: Jennifer Johnson,
Deputy Commissioner, Administration on Disabilities, Administration for
Community Living.
Letters of Assurance should be submitted electronically via email
to [email protected].
2. Submission Dates and Times
To receive consideration, Letters of Assurance must be submitted by
11:59 p.m. Eastern Time on February 11, 2022. Letters of Assurance
should be submitted electronically via email and have an electronic
time stamp indicating the date/time submitted.
VII. Agency Contacts
1. Programmatic and Submission Issues
Direct programmatic and submission inquiries to [email protected].
Dated: January 6, 2022.
Alison Barkoff,
Principal Deputy Administrator.
[FR Doc. 2022-00401 Filed 1-11-22; 8:45 am]
BILLING CODE 4154-01-P
